Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/23/1996EP0654995B1 4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as antitumor agents
10/23/1996EP0652751B1 Injection and injection kit containing omeprazole and its analogs
10/23/1996EP0646110B1 N-substituted 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents
10/23/1996EP0643699B1 6-(2-hydroxyethylaminoalkyl)-5,11-dioxo-5,6-dihydro-11h- indeno[1,2-c]isoquinolines and their use as antineoplastic agents
10/23/1996EP0640143A4 Senescent cell derived inhibitors of dna synthesis.
10/23/1996EP0600950B1 Amide tetrazole acat inhibitors
10/23/1996EP0591443B1 Use of cosmetic compositions containing oligosaccharides
10/23/1996EP0589981B1 Oral-administration forms of a medicament containing pantoprazol
10/23/1996EP0576643B1 Controlled release oxycodone compositions
10/23/1996EP0574383B1 Color modified melanins and methods for their preparation and use
10/23/1996EP0541524B1 Food and feedstuff
10/23/1996EP0517876B1 Therapeutic benzazepine compounds
10/23/1996EP0502048B1 Use of caffeine in the treatment of herpes simplex virus infections
10/23/1996EP0416094B1 Parathyroid hypertensive factor
10/23/1996CN1134155A Androstenones
10/23/1996CN1134153A Matrix metalloprotease inhibitors
10/23/1996CN1134151A Pyrazine carboxamide derivs., their production and their use in medicaments
10/23/1996CN1134150A Quinazoline deriv.
10/23/1996CN1134149A Phenylindole compounds
10/23/1996CN1134148A Antithrombotic amidinophenylalanine and amidinopyridylalanine derivs
10/23/1996CN1134147A 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles useful as memory enhancers
10/23/1996CN1134146A Benzoyl guanidines, their production and their use in medicaments
10/23/1996CN1134113A Method for inducing antigen-specific T cell tolerance
10/23/1996CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
10/23/1996CN1134108A Beads for controlled release and pharmaceutical preparation contg. same
10/23/1996CN1134107A Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
10/23/1996CN1133844A Osa-or thia-aliphatically bridged quinoxaline-2,3-diones
10/23/1996CN1133843A Thienopyridone
10/23/1996CN1133841A Use of 1,2-bridged 1,4-dihydropyridines as medicaments
10/23/1996CN1133840A Indolepiperidine derivatives
10/23/1996CN1133839A Aroyl-piperidine derivatives
10/23/1996CN1133837A Substituted 1H-imidazoles
10/23/1996CN1133716A Extrior-use medicine for treatment of alopecia seborrhoeica
10/23/1996CN1133712A Use of 12, 24-dihydroxy vitamin D2
10/23/1996CN1133711A Therapeutic sterilization medicine composition
10/23/1996CN1133710A Multidrug resistance reverse agent for tumor
10/23/1996CN1133709A Process for preparing controlled-release tablet of diltiazem hydrochloride
10/23/1996CN1033089C Process for preparation of aryl piperazinyl-heterocyclic compounds
10/23/1996CN1033088C Process for preparing thiazolylbenzofuran derivs.
10/23/1996CN1033087C 7-(subtd.)-8-(substd.-9-|(substd.glycyl) amido¨-6-demethyl-6-deoxytetracyclines
10/23/1996CN1033086C Process for preparing phenylalkyl acid derivs.
10/22/1996US5567859 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
10/22/1996US5567841 α-phosphonosulfonate squalene synthetase inhibitors and method
10/22/1996US5567831 Non-steroidal sulfatase inhibitor compounds and their method of use
10/22/1996US5567828 For treatment of post-menopausal diseases, i.e., osteoporosis, cardiovascular disorders, cancer
10/22/1996US5567824 Catalyzing the cyclization in presence of a solvent and a proton acceptor
10/22/1996US5567820 Therapy for bone diseases
10/22/1996US5567818 Reduction; separation; dehydration
10/22/1996US5567817 Triazole antifungal agents
10/22/1996US5567813 Acylation in presence of a solvent and a base
10/22/1996US5567765 Artificial blood, contrast agent, organ preservative
10/22/1996US5567738 Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-Naphthoquinone for the treatment of cancer
10/22/1996US5567736 Use of a choline salt to inhibit fatty liver in patients receiving total parenteral nutrition
10/22/1996US5567735 Therapeutic amides
10/22/1996US5567734 Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
10/22/1996US5567733 Mucous membrane
10/22/1996US5567732 Culture product of diatoms
10/22/1996US5567731 Gaba-ergic modulation of eye growth
10/22/1996US5567729 Farnesyl compounds as farnesyl protein transferase inhibitors to treat ras induced tumor growth
10/22/1996US5567728 Receptor ligands
10/22/1996US5567726 Selective agonists of 5-hydroxytryptamine-like receptors; useful in treatment of migraine and associated disorders
10/22/1996US5567725 Antidiabetic agent
10/22/1996US5567724 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
10/22/1996US5567722 Diuretics
10/22/1996US5567721 Aromatic urea compound for skin disorder, rheumatic disease, respiratory disorder and eye disorder
10/22/1996US5567720 Pharmaceutically active agents that impede amyloid formation in vivo
10/22/1996US5567719 Thiadiazoles and their use as antipicornaviral agents
10/22/1996US5567718 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors
10/22/1996US5567716 Trans and cis traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity
10/22/1996US5567715 1-benzothiophene derivatives
10/22/1996US5567714 Methods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide Y
10/22/1996US5567713 Hypoglycemic agents
10/22/1996US5567712 Naphthyl compounds, intermediates, compositions and methods
10/22/1996US5567711 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
10/22/1996US5567709 Carbamates of rapamycin
10/22/1996US5567708 Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
10/22/1996US5567707 Acronycine analogues
10/22/1996US5567706 Method for treating impotence
10/22/1996US5567704 Administering to treat hair loss caused by cytoreductive therapies
10/22/1996US5567702 Combination of pyrimidine derivatives and retinoids, as separate components, for inducing and stimulating hair growth and reducing its loss
10/22/1996US5567700 Useful for treating asthma
10/22/1996US5567698 Bacterisides
10/22/1996US5567697 17-(4-pyridazinyl) -5β, 14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
10/22/1996US5567696 Treatment of systemic lupus erythematosus with dehydroepiandrosterone
10/22/1996US5567695 Side effect reduction
10/22/1996US5567694 17-Aryl and 17-heterocyclyl-5β,14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
10/22/1996US5567693 Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
10/22/1996US5567692 9-[(substituted glycyl) amido)]-6-demethyl-6-deoxytetracyclines
10/22/1996US5567689 Methods for increasing uridine levels with L-nucleosides
10/22/1996US5567688 L-nucleosides for the treatment of hepatitis B-virus
10/22/1996US5567686 Method for protection against genotoxic mutagenesis
10/22/1996US5567684 Synthetic ganglioside derivatives
10/22/1996US5567683 Antiinflammatory agents
10/22/1996US5567604 Anti-viral guanosine-rich oligonucleotides
10/22/1996US5567597 Hydrolytic enzyme inhibitors/inactivators and methods for using same
10/22/1996US5567441 Sustained release pellets comprising multilayer polymeric membrane
10/22/1996US5567437 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation
10/22/1996US5567420 Lotion which is temporarily colored upon application
10/22/1996US5567409 Administering a tetrapyrrole carboxylic acid in sufficient quantity to accumulate in arthritic lesion; applying light to cause it to produce fluorescence
10/22/1996CA2174473A1 Heteroatom-containing benzocyclopentane oxazolidinones
1 ... 6867 6868 6869 6870 6871 6872 6873 6874 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 ... 7860